ArticleHeliyon2018

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Qinfang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.